In contrast, PAD4 inhibition, and therefore inhibition of NET formation, reduced infarct size, rescued cardiac function, and ameliorated neutrophil recruitment and NET formation in MI, all factors that lower the likelihood for arrhythmia onset (243). The gene discussed is PADI4; the disease is cardiac arrhythmia.